Upgrade to SI Premium - Free Trial

OncoCyte (OCX) Misses Q1 EPS by 113c

May 15, 2024 4:47 PM

OncoCyte (NASDAQ: OCX) reported Q1 EPS of ($1.13). Revenue for the quarter came in at $180 thousand.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

Categories

Earnings